Other substances

Salvianolic acid A

A stilbenoid.

Phase of research

Potential treatment - theoretical effect

How it helps

Antiviral

Drug status

Experimental

Supporting references

Contradictory references

AI-suggested references

Clinical trials

General information

Salvianolic acid A on PubChem

Structure image - Salvianolic acid A

C1=CC(=C(C=C1C[C@H](C(=O)O)OC(=O)/C=C/C2=C(C(=C(C=C2)O)O)/C=C/C3=CC(=C(C=C3)O)O)O)O

Supporting references

Link	Tested on	Impact factor	Notes	Publication date
Screening of drug databank against WT and mutant main protease of SARS-CoV-2: Towards finding potential compound for repurposing against COVID-19 3CLpro Small molecule In silico	in silico	2.80	Predicted to bind SARS-CoV-2 3C-like protease with N142S or T190I mutations.	Feb/23/2021

AI-suggested references

Link	Publication date
Identification of natural compounds as SARS-CoV-2 entry inhibitors by molecular docking-based virtual screening with bio-layer interferometry.	Aug/14/2021
Oridonin Inhibits SARS-CoV-2 by Targeting Its 3C-Like Protease.	Mar/13/2022
Three salvianolic acids inhibit 2019-nCoV spike pseudovirus viropexis by binding to both its RBD and receptor ACE2	Jul/30/2020
Molecular docking analysis of SARS-CoV-2 linked RNA dependent RNA polymerase (RdRp) with compounds from Plectranthus amboinicus	May/30/2022
In silico drug discovery of major metabolites from spices as SARS-CoV-2 main protease inhibitors.	Oct/08/2020